Clinical Trials Logo

Superimposed Pre-Eclampsia clinical trials

View clinical trials related to Superimposed Pre-Eclampsia.

Filter by:
  • None
  • Page 1

NCT ID: NCT05542654 Completed - Pre-Eclampsia Clinical Trials

The Effect of Foot Massage on Blood Pressure and Anxiety Levels in Pregnants With Hypertension

Start date: November 5, 2020
Phase: N/A
Study type: Interventional

This research was conducted as a prospective, experimental and randomised controlled research to determine the effect of foot massage applied to pregnant women with hypertension on blood pressure and anxiety levels.

NCT ID: NCT04660032 Active, not recruiting - Preeclampsia Clinical Trials

Nudge to Drive Transitions of Care

REMIND
Start date: February 8, 2021
Phase: N/A
Study type: Interventional

Hypertensive disorders of pregnancy (HDP) are stress tests which may identify women at high risk of future cardiovascular disease (CVD), the leading cause of death among women. Given the public health impact of HDP and CVD, there is a compelling need to identify scalable interventions to improve preventative care among women who have risk identified during pregnancy. We will examine the effects of delivering electronic prompts to obstetric care providers (nudge) on transitions of care in the postpartum period. We will conduct a pilot randomized trial to evaluate whether this nudge intervention will improve postpartum counseling and lead to greater follow-up with preventative care providers among women with HDP.

NCT ID: NCT03815110 Completed - Clinical trials for Gestational Hypertension

Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification

PRAECIS
Start date: December 20, 2018
Phase:
Study type: Observational

The purpose of this study is to 1. Identify a cut-off for the ratio of the serum proteins soluble FMS-like Tyrosine Kinase 1 (sFLT-1) and placental growth factor (PlGF) that identifies women will who develop preeclampsia with severe features within 2 weeks of testing (clinically positive) from those who do not develop preeclampsia with severe features within 2 weeks of testing (clinically negative) among preterm pregnant women with hypertensive disorders of pregnancy. And 2. To validate the cut-off the ratio of sFLT-1 and PlGF and to validate the performance of the automated assays used to find the cut-off. Test performance includes positive predictive value, negative predictive value, sensitivity, and specificity. Subjects will provide blood, urine, and saliva samples at the time of enrollment. Samples will be frozen for batch assessment of sFLT-1 and PlGF levels by automated assays. Clinicians, subjects, and researchers will be blinded to protein level assessment, therefore assay results will not affect clinical management.

NCT ID: NCT03298802 Recruiting - Pre-Eclampsia Clinical Trials

Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide

Start date: November 21, 2017
Phase: Phase 3
Study type: Interventional

Postpartum prophylactic HCTZ administration for prevention and relapse of preeclampsia or gestational hypertension.